New Podcast: Verdict in Cancer Immunotherapy IP Case

Harris Beach PLLC
Contact
One of the most interesting and promising areas of medical research today involves the use of T-Cell therapies, which offer hope and promise as a new approach to cancer treatment. It has also made for a robust climate for intellectual property disputes.

Earlier this year, Juno Therapeutics won a $1 billion judgment against Gilead’s Kite Pharma in connection with alleged infringement of U.S. Patent No. 7,446,190, entitled “Nucleic Acid See more +

One of the most interesting and promising areas of medical research today involves the use of T-Cell therapies, which offer hope and promise as a new approach to cancer treatment. It has also made for a robust climate for intellectual property disputes.

Earlier this year, Juno Therapeutics won a $1 billion judgment against Gilead’s Kite Pharma in connection with alleged infringement of U.S. Patent No. 7,446,190, entitled “Nucleic Acid Encoding Chimeric T Cell Receptors.”

The patent relates to CAR T-cell therapy a form of immunotherapy that uses specially altered T cells — a part of the immune system — to fight cancer. The invention was developed by inventors at Sloan Kettering and licensed to Juno by a Sloan Kettering entity.

In this episode of the Harris Beach Podcast, partner Laura Smalley discusses the implications of the Juno v. Kite pharma case, including the use of the “reasonable royalty” concept to support a large damages award. Laura is an authority on intellectual property law in the areas of pharmaceuticals, medical devices and life sciences. She is a regular contributor to the American Intellectual Property Law Association’s Biotech Buzz newsletter as well as a presenter on regulatory and IP issues for immunotherapies, including Car-T and antibody technologies.

See less -

Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Harris Beach PLLC | Attorney Advertising

Written by:

Harris Beach PLLC
Contact
more
less

Harris Beach PLLC on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.